Compliance packaging for over-the-counter drug products
نویسندگان
چکیده
منابع مشابه
Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
The Food and Drug Administration (FDA) is delaying the compliance dates for the final rule for over-the-counter (OTC) sunscreen drug products that published in the Federal Register of June 17, 2011 (76 FR 35620). The final rule establishes labeling and effectiveness testing for certain OTC sunscreen products containing specified active ingredients and marketed without approved applications. It ...
متن کاملMining aggregates of over-the-counter products for syndromic surveillance
There has recently been a surge of research efforts aimed at very early detection of disease outbreaks. An important strategy for improving the timeliness of outbreak detection is to identify signals that occur early in the epidemic process. We have developed a novel algorithm to identify aggregates of "similar" over-the-counter products that have strong association with a given disease. This p...
متن کاملOver-the-Counter Products In Line for User Fee Program.
Over-the-counter products in line for user fee program.
متن کاملAnticaries Drug Products for Over-the-Counter Human Use; Use of Intraoral Appliance Models for Compliance With Biological Testing Requirements; Request for Information and Comments
The Food and Drug Administration (FDA) is requesting information and comments on the use of intraoral appliance (IOA) models as a substitute for the animal caries reduction (“rat caries models”) biological test required by the monograph for over-the-counter (OTC) anticaries drug products to demonstrate the availability of fluoride in OTC dentifrice formulations. This notice is part of the ongoi...
متن کاملCold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
The Food and Drug Administration (FDA) is issuing a final rule to amend the final monograph (FM) for over-the-counter (OTC) nasal decongestant drug products (drug products used to relieve nasal congestion due to a cold, hay fever, or other upper respiratory allergies) to add phenylephrine bitartrate (PEB), both individually and in combination drug products in an effervescent dosage form, as gen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Public Health
سال: 2009
ISSN: 0943-1853,1613-2238
DOI: 10.1007/s10389-008-0233-6